1. M.K. DeGorter, G. Conseil, R.G. Deeley, R.L. Campbell and S.P.C. Cole. Molecular modeling of the human multidrug resistance protein 1 (MRP1/ABCC1). Biochem. Biophys. Res. Commun. 365: 29-34 (2008).
  2. A.J. Slot, D.D. Wise, R.G. Deeley, T.J. Monks and S.P.C. Cole. Modulation of human MRP1 (ABCC1) and MRP2 (ABCC2) transport by endogenous and exogenous glutathione-conjugated catechol metabolites. Drug Metab. Dispos. 36: 552-560 (2008).
  3. I.J. Létourneau, A. Nakajima, R.G. Deeley and S.P.C. Cole. Role of proline 1150 in functional interactions between the membrane spanning domains and nucleotide binding domains of the MRP1 (ABCC1) transporter. Biochem. Pharmacol. 75: 1659-1669 (2008).
  4. Md. T. Hoque and S.P.C. Cole. Downregulation of NHERF1 increases expression and function of multidrug resistance protein 4 (MRP4). Cancer Res. 68: 4802-4809 (2008).
  5. P.E. Bandler, C.J. Westlake, C.E. Grant, S.P.C. Cole and R.G. Deeley.  Identification of regions in human multidrug resistance protein (MRP) 2 required for apical membrane localization. Mol. Pharmacol. 74: 9-19 (2008).
  6. A. Rothnie, G. Conseil, A.Y.T. Lau, R.G. Deeley and S.P.C. Cole. Mechanistic differences between GSH transport by MRP1 (ABCC1) and GSH modulation of MRP1-mediated transport.  Mol. Pharmacol. 74: 1630-1640 (2008).
  7. C.E. Grant, M. Gao, M.K. DeGorter S.P.C. Cole and R.G. Deeley. Structural determinants of substrate specificity differences between human multidrug resistance protein (MRP) 1 (ABCC1) and MRP3 (ABCC3). Drug Metab. Dispos. 36: 2571-2581 (2008).
  8. Qin, J. Zheng, C.E. Grant, Z. Jia, S.P.C. Cole and R.G. Deeley. Residues responsible for the asymmetric function of the nucleotide binding domains of multidrug resistance protein (MRP) 1. Biochemistry 47: 13952-13965 (2008).